Suppr超能文献

中国ST段抬高型心肌梗死并发心脏骤停和心源性休克的回顾性多中心研究。

Cardiac arrest and cardiogenic shock complicating ST-segment elevation myocardial infarction in China: A retrospective multicenter study.

作者信息

Liu Shao-Shuai, Wang Juan, Tan Hui-Qiong, Yang Yan-Min, Zhu Jun

机构信息

Department of Cardiology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, 758 Hefei Road, Qingdao, Shandong, 266035, China.

Emergency Center, Fuwai Hospital, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100037, China.

出版信息

Heliyon. 2024 Jul 6;10(13):e34070. doi: 10.1016/j.heliyon.2024.e34070. eCollection 2024 Jul 15.

Abstract

BACKGROUND

Data on the effect of cardiac arrest (CA), cardiogenic shock (CS), and their combination on the prognosis of Chinese patients with ST-segment elevation myocardial infarction (STEMI) are limited. The present study sought to evaluate the clinical outcomes of STEMI complicated by CA and CS, and to identify the risk factors for CA or CS.

METHODS

This study included 7468 consecutive patients with STEMI in China. The patients were divided into 4 groups (CA + CS, CA only, CS only, and No CA or CS). The endpoints were 30-day all-cause death and major adverse cardiovascular events. A Cox proportional hazards regression analysis was performed.

RESULTS

CA, CS, and their combination were noted in 332 (4.4 %), 377 (5.0 %), and 117 (1.6 %) among all patients. During the 30-day follow-up, 817 (10.9 %) all-cause deaths and 964 (12.9 %) major adverse cardiovascular events occurred, and the incidence of all-cause mortality (3.6 %, 62.3 %, 74.1 %, 83.3 %) and major adverse cardiovascular events (5.4 %, 67.1 %, 75.0 %, and 87.2 %) significantly increased in the No CA or CS, CS only, CA only, and CA + CS groups, respectively. In the multivariate Cox regression models, compared with the No CA or CS group, the CA + CS, CA, and S-only groups were associated with an increased risk of all-cause death and major adverse cardiovascular events. Patients with CA + CS had the highest risk of all-cause death (hazard ratio [HR], 25.259 [95 % confidence interval (CI) 19.221-33.195]) and major adverse cardiovascular events (HR 19.098, 95%CI 14.797-24.648).

CONCLUSIONS

CA, CS, and their combination were observed in approximately 11 % of Chinese patients with STEMI, and were associated with increased risk for 30-day mortality and major adverse cardiovascular events in Chinese patients with STEMI.

摘要

背景

关于心脏骤停(CA)、心源性休克(CS)及其联合情况对中国ST段抬高型心肌梗死(STEMI)患者预后影响的数据有限。本研究旨在评估STEMI合并CA和CS的临床结局,并确定发生CA或CS的危险因素。

方法

本研究纳入了中国7468例连续的STEMI患者。患者被分为4组(CA + CS、仅CA、仅CS以及无CA或CS)。终点为30天全因死亡和主要不良心血管事件。进行了Cox比例风险回归分析。

结果

在所有患者中,CA、CS及其联合情况分别见于332例(4.4%)、377例(5.0%)和117例(1.6%)。在30天随访期间,发生了817例(10.9%)全因死亡和964例(12.9%)主要不良心血管事件,全因死亡率(3.6%、62.3%、74.1%、83.3%)和主要不良心血管事件发生率(5.4%、67.1%、75.0%、87.2%)在无CA或CS、仅CS、仅CA以及CA + CS组中分别显著增加。在多变量Cox回归模型中,与无CA或CS组相比,CA + CS、CA和仅CS组全因死亡和主要不良心血管事件风险增加。CA + CS患者全因死亡风险最高(风险比[HR],25.259[95%置信区间(CI)19.221 - 33.195])和主要不良心血管事件风险最高(HR 19.098,95%CI 14.797 - 24.648)。

结论

在中国STEMI患者中,约11%观察到CA、CS及其联合情况,并且与中国STEMI患者30天死亡率和主要不良心血管事件风险增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6714/11279725/8eabcfdffa57/gr1.jpg

相似文献

1
Cardiac arrest and cardiogenic shock complicating ST-segment elevation myocardial infarction in China: A retrospective multicenter study.
Heliyon. 2024 Jul 6;10(13):e34070. doi: 10.1016/j.heliyon.2024.e34070. eCollection 2024 Jul 15.
2
Long-term outcomes of cardiogenic shock and cardiac arrest complicating ST-elevation myocardial infarction according to timing of occurrence.
Eur Heart J Open. 2024 Sep 3;4(5):oeae075. doi: 10.1093/ehjopen/oeae075. eCollection 2024 Sep.
3
Cardiogenic shock and cardiac arrest complicating ST-segment elevation myocardial infarction in the United States, 2000-2017.
Resuscitation. 2020 Oct;155:55-64. doi: 10.1016/j.resuscitation.2020.07.022. Epub 2020 Aug 2.
4
Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac Arrest.
JACC Cardiovasc Interv. 2020 May 25;13(10):1211-1219. doi: 10.1016/j.jcin.2020.04.004.
6
7
Renal impairment and mortality in patients with STEMI and cardiogenic shock/cardiac arrest.
Catheter Cardiovasc Interv. 2023 Aug;102(2):179-190. doi: 10.1002/ccd.30753. Epub 2023 Jun 28.
9
Treatment Intensity for the Management of Cardiogenic Shock: Comparison Between STEMI and Non-STEMI.
JACC Adv. 2023 May 26;2(3):100314. doi: 10.1016/j.jacadv.2023.100314. eCollection 2023 May.
10
Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients.
Eur Heart J Acute Cardiovasc Care. 2018 Feb;7(1):7-15. doi: 10.1177/2048872617706503. Epub 2017 Apr 28.

本文引用的文献

1
Contemporary Management of Concomitant Cardiac Arrest and Cardiogenic Shock Complicating Myocardial Infarction.
Mayo Clin Proc. 2022 Dec;97(12):2333-2354. doi: 10.1016/j.mayocp.2022.06.027.
2
Impact of glycemic gap on 30-day adverse outcomes in patients with acute ST-segment elevation myocardial infarction.
Atherosclerosis. 2022 Nov;360:34-41. doi: 10.1016/j.atherosclerosis.2022.10.003. Epub 2022 Oct 9.
5
Mortality and Heart Failure Hospitalization Among Young Adults With and Without Cardiogenic Shock After Acute Myocardial Infarction.
J Card Fail. 2023 Jan;29(1):18-29. doi: 10.1016/j.cardfail.2022.08.012. Epub 2022 Sep 18.
8
Esmolol to Treat the Hemodynamic Effects of Septic Shock: A Randomized Controlled Trial.
Shock. 2022 Apr 1;57(4):508-517. doi: 10.1097/SHK.0000000000001905.
9
Prognostic implications and outcomes of cardiac arrest among contemporary patients with STEMI treated with PCI.
Resusc Plus. 2021 Jul 15;7:100149. doi: 10.1016/j.resplu.2021.100149. eCollection 2021 Sep.
10
Use of Post-Acute Care Services and Readmissions After Acute Myocardial Infarction Complicated by Cardiac Arrest and Cardiogenic Shock.
Mayo Clin Proc Innov Qual Outcomes. 2021 Feb 8;5(2):320-329. doi: 10.1016/j.mayocpiqo.2020.12.006. eCollection 2021 Apr.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验